Global Fairness in Drug Pricing Act

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 3493 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 3493 To reduce prescription drug prices by aligning U.S. prices with international benchmarks. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES May 19, 2025 Mr. Khanna (for himself, Mrs. Luna, Ms. Kaptur, and Mr. Biggs of Arizona) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To reduce prescription drug prices by aligning U.S. prices with international benchmarks. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Global Fairness in Drug Pricing Act''. SEC. 2. DRUG PRICING. (a) Most-favored Nation Price Targets.--Not later than 30 days after the date of enactment of this Act, the Secretary of Health and Human Services shall, in coordination with the Administrator of the Centers for Medicare & Medicaid Services and other heads of relevant Federal agencies--propose a rulemaking plan to impose most-favored- nation price targets to pharmaceutical manufacturers to ensure that prices for pharmaceutical products paid by patients in the United States are comparable to the prices for such products paid by comparably developed countries. (b) Importation by Individuals.--The Secretary of Health and Human Services shall certify to Congress that importation under section 804(j) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 384(j)) will pose no risk to the health and safety of the public and